Use of Angiotensin II for Post Cardiopulmonary Bypass Vasoplegic Syndrome
- 1 July 2019
- journal article
- editorial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 108 (1) , e5-e7
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Hydroxocobalamin for the Treatment of Vasoplegia: A Review of Current Literature and Considerations for UseJournal of Cardiothoracic and Vascular Anesthesia, 2019
- When All Else Fails: Novel Use of Angiotensin II for Vasodilatory Shock: A Case ReportA&A Practice, 2018
- Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin IICritical Care Medicine, 2018
- 6: EFFECT OF DISEASE SEVERITY ON SURVIVAL IN PATIENTS RECEIVING ANGIOTENSIN II FOR VASODILATORY SHOCKCritical Care Medicine, 2018
- Angiotensin II for the Treatment of Vasodilatory ShockNew England Journal of Medicine, 2017
- Clinical Experience With IV Angiotensin II Administration: A Systematic Review of SafetyCritical Care Medicine, 2017
- Methylene BlueAnesthesia & Analgesia, 2016
- Selecting a Vasopressor Drug for Vasoplegic Shock After Adult Cardiac Surgery: A Systematic Literature ReviewThe Annals of Thoracic Surgery, 2007